139 related articles for article (PubMed ID: 9196600)
1. An account of the quality of life of patients after treatment for non-functioning pituitary tumours.
Page RC; Hammersley MS; Burke CW; Wass JA
Clin Endocrinol (Oxf); 1997 Apr; 46(4):401-6. PubMed ID: 9196600
[TBL] [Abstract][Full Text] [Related]
2. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls.
Li Voon Chong JS; Groves T; Foy P; Wallymahmed ME; MacFarlane IA
Clin Endocrinol (Oxf); 2002 Feb; 56(2):175-81. PubMed ID: 11874408
[TBL] [Abstract][Full Text] [Related]
3. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.
Li Voon Chong JS; Benbow S; Foy P; Wallymahmed ME; Wile D; MacFarlane IA
Clin Endocrinol (Oxf); 2000 Nov; 53(5):551-9. PubMed ID: 11106915
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease.
Toogood AA; Jones J; O'Neill PA; Thorner MO; Shalet SM
Clin Endocrinol (Oxf); 1998 May; 48(5):569-76. PubMed ID: 9666868
[TBL] [Abstract][Full Text] [Related]
5. Hypopituitarism following external radiotherapy for pituitary tumours in adults.
Littley MD; Shalet SM; Beardwell CG; Ahmed SR; Applegate G; Sutton ML
Q J Med; 1989 Feb; 70(262):145-60. PubMed ID: 2594955
[TBL] [Abstract][Full Text] [Related]
6. Influences on quality of life in GH deficient adults and their effect on response to treatment.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
[TBL] [Abstract][Full Text] [Related]
7. Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects.
Malik IA; Foy P; Wallymahmed M; Wilding JP; MacFarlane IA
Clin Endocrinol (Oxf); 2003 Jul; 59(1):75-81. PubMed ID: 12807507
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of free insulin-like growth factor-I measurement on the diagnosis and follow-up treatment of growth hormone-deficient adult patients.
Musolino NR; Da Cunha Neto MB; Marino Júnior R; Giannella-Neto D; Bronstein MD
Clin Endocrinol (Oxf); 1999 Apr; 50(4):441-9. PubMed ID: 10468902
[TBL] [Abstract][Full Text] [Related]
9. The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects.
Wallymahmed ME; Foy P; MacFarlane IA
Clin Endocrinol (Oxf); 1999 Sep; 51(3):333-8. PubMed ID: 10469013
[TBL] [Abstract][Full Text] [Related]
10. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia.
Beentjes JA; Tjeerdsma G; Sluiter WJ; Dullaart RP
Clin Endocrinol (Oxf); 1996 Oct; 45(4):391-8. PubMed ID: 8959076
[TBL] [Abstract][Full Text] [Related]
11. Growth in children with craniopharyngioma following surgery.
Tiulpakov AN; Mazerkina NA; Brook CG; Hindmarsh PC; Peterkova VA; Gorelyshev SK
Clin Endocrinol (Oxf); 1998 Dec; 49(6):733-8. PubMed ID: 10209560
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life.
Noad R; Narayanan KR; Howlett T; Lincoln NB; Page RC
Clin Oncol (R Coll Radiol); 2004 Jun; 16(4):233-7. PubMed ID: 15214645
[TBL] [Abstract][Full Text] [Related]
13. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
[TBL] [Abstract][Full Text] [Related]
14. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the growth hormone and insulin-like growth factor axis in long-term survivors of childhood brain tumours.
Achermann JC; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1998 Nov; 49(5):639-45. PubMed ID: 10197080
[TBL] [Abstract][Full Text] [Related]
16. Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center study.
Baum HB; Biller BM; Katznelson L; Oppenheim DS; Clemmons DR; Cannistraro KB; Schoenfeld DA; Best SA; Klibanski A
J Clin Endocrinol Metab; 1996 Jan; 81(1):84-92. PubMed ID: 8550799
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours.
Spoudeas HA; Charmandari E; Brook CG
Med Pediatr Oncol; 2003 Apr; 40(4):224-9. PubMed ID: 12555249
[TBL] [Abstract][Full Text] [Related]
18. Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study.
Schmiegelow M; Lassen S; Poulsen HS; Feldt-Rasmussen U; Schmiegelow K; Hertz H; Müller J
Clin Endocrinol (Oxf); 2000 Aug; 53(2):191-7. PubMed ID: 10931100
[TBL] [Abstract][Full Text] [Related]
19. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Shalet SM
Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947
[TBL] [Abstract][Full Text] [Related]
20. The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status.
Toogood AA; Ryder WD; Beardwell CG; Shalet SM
Clin Endocrinol (Oxf); 1995 Jul; 43(1):97-103. PubMed ID: 7641416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
